Did you know?

BOSTON -- (BUSINESS WIRE)--Jan. 17, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2022 financial results on Tuesday, February 7, 2023 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET .The average trading volume of VRTX on November 24, 2023 was 1.14M shares. VRTX) stock’s latest price update. Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX)’s stock price has dropped by -0.44 in relation to previous closing price of 354.78. Nevertheless, the company has seen a gain of 1.11% in its stock price over the last five …Nov 6, 2023 · BOSTON -- (BUSINESS WIRE)--Nov. 6, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2023, raised full year 2023 guidance for product revenue and reiterated full year 2023 guidance for operating expenses. “Vertex has delivered another strong ... VRTX Markets / USA / Stocks / Health Technology / Pharmaceuticals: Major / VRTX Vertex Pharmaceuticals Incorporated VRTXNASDAQ VRTXNASDAQ See on …NASDAQ: VRTX Vertex Pharmaceuticals. Market Cap. $91B. Today's Change (1.08%) $3.81. ... Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors. by Zacks Equity Research Published on October 27,2023. In the closing of the recent trading day, Vertex ...Dec 27, 2022 · Vertex Pharmaceuticals (VRTX-0.05%) has beaten the bear market by far this year: The stock is heading for a 30% gain. But this isn't just a stroke of good luck. Investors are recognizing the ... According to 27 analysts, the average rating for VRTX stock is "Buy." The 12-month stock price forecast is $372.96, which is an increase of 6.21% from the latest price.Dec 1, 2023 · 19 brokers have issued 12-month price targets for Vertex Pharmaceuticals' shares. Their VRTX share price targets range from $296.00 to $456.00. On average, they expect the company's stock price to reach $376.13 in the next year. This suggests a possible upside of 7.1% from the stock's current price. View analysts price targets for VRTX or view ... Dec 1, 2023 · 19 brokers have issued 12-month price targets for Vertex Pharmaceuticals' shares. Their VRTX share price targets range from $296.00 to $456.00. On average, they expect the company's stock price to reach $376.13 in the next year. This suggests a possible upside of 7.1% from the stock's current price. View analysts price targets for VRTX or view ... 2021. 219.6. 2022. 288.78. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown.VRTX’s stock style is Large Growth. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are ...Biotech companies CRISPR Therapeutics ( CRSP -2.10%) and Vertex Pharmaceuticals ( VRTX 0.16%) are often mentioned in the same sentence. That's because they have been partnering to develop a ...Shares of Vertex Pharmaceuticals ( VRTX 1.38%) gained a stunning 33.5% in 2023 while the Nasdaq Composite index that it's a part of sank 33.1% lower. Of course, one very good year doesn't ...Find the latest CRISPR Therapeutics AG (CRSP) stock May 1, 2023 · BOSTON -- (BUSINESS WIRE)--M Vertex Pharmaceuticals Incorporated’s trailing 12-month revenue is $9.5 billion with a 35.4% profit margin. Year-over-year quarterly sales growth most recently was 13.5%. Analysts expect adjusted earnings to reach $14.709 per share for the current fiscal year. Other News for VRTX Vertex Pharmaceuticals Inc. s Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors. by Zacks Equity Research Published on October 27,2023. In the closing of the recent trading day, Vertex ... Jun 3, 2023 · This company might be worth a premium. A strug

Vertex Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target VRTX. High $ 456.00: Median $ 394.00: Low $ 325.00: Average $ 399.46 ...VANCOUVER, British Columbia, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FRA: AA3) ("Vortex” or the "Company") is pleased to annou. Find the latest Vortex Energy Corp. (VRTX.CN) stock quote, history, news and other vital information to help you with your stock trading and investing. May 2, 2023 · On today's stock market, VRTX stock rose 0.3% to close at 346.03. Vertex is the leading maker of cystic fibrosis treatments. Product sales climbed 13% to $2.37 billion and beat forecasts for $2.34 ... May 3, 2023 · 7. A cash stockpile of $11.5 billion. Last, but not least, Vertex ended the first quarter of 2023 with a cash stockpile (including cash equivalents and marketable securities) of $11.5 billion. The ... The stock price of Vertex Pharmaceuticals (NASDAQ: VRTX) has seen an 8.1% drop over the last five trading days, after the company announced that it will discontinue the clinical trials for VX-864 ...

Find out all the key statistics for Vertex Pharmaceuticals Incorporated (VRTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.Vertex Pharmaceuticals Price Performance. Shares of NASDAQ VRTX opened at $353.60 on Monday. The stock has a market cap of $91.12 billion, a PE ratio of 26.34, a price-to-earnings-growth ratio of ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. One VRTX share bought prior to August 24th, 200. Possible cause: VRTX’s stock has surged 3.9% over the past six months and 22.3% year-to-date.